MAQI2 Anticoagulation Toolkit vs AF Stroke Risk
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
MAQI2 Anticoagulation Toolkit
This mobile application offers healthcare professionals a current and user-friendly guide for safer and more effective management of patients on anticoagulation therapy. Developed by leading experts, it incorporates the latest research and guidelines.
- Up-to-date resource
- Easy-to-use interface
- Patient management
- Latest guidelines
- Expert-developed content
Read full descriptionHide full description
This mobile app provides healthcare practitioners with an up-to-date, easy-to-use resource for managing anticoagulation patients more safely and effectively. The content was developed by the Michigan Anticoagulation Quality Improvement Initiative (MAQI2), a Blue Cross Blue Shield/Blue Care Network of Michigan sponsored consortium of anticoagulation clinics and experts from across the state of Michigan, and is based on the latest guidelines and research.
AF Stroke Risk
This medical app assists practitioners in predicting stroke, TIA, or embolism risk using CHA₂DS₂-VASc and CHADS₂ scores for patients with atrial fibrillation. It provides precise calculations to help determine necessary anticoagulant or antiplatelet therapy.
- Stroke risk prediction
- CHA₂DS₂-VASc score calculation
- CHADS₂ score calculation
- Embolism risk assessment
- TIA risk assessment
- Easy to use interface
Read full descriptionHide full description
"AF Stroke Risk - Atrial Fibrillation Evaluation" is a mobile app designed to help medical practitioner to predict the risk of stroke, transient ischemic attack (TIA), or embolism based on CHA₂DS₂-VASc and CHADS₂ Score. Atrial fibrillation (AF) is the most common sustained cardiac rhythm disorder, which is associated with a substantial risk of mortality and morbidity from stroke and thromboembolism (TE) event. There are several features of "AF Stroke Risk - Atrial Fibrillation Evaluation", namely: - Simple and very easy to use. - Precise calculation with CHA₂DS₂-VASc and CHADS₂ score. - Determine the risk of atrial fibrillation complication, such as stroke, transient ischemic attack, and embolism. - It is totally free. Download now! The CHA₂DS₂-VASc and CHADS₂ score in "AF Stroke Risk - Atrial Fibrillation Evaluation" are clinical prediction rules for estimating the risk of stroke in patients with non-rheumatic atrial fibrillation (AF), a common and serious heart arrhythmia associated with thromboembolic stroke. Such a score is used to determine whether or not treatment is required with anticoagulant or antiplatelet therapy. This schema could improve the approach to stroke risk stratification in patients with atrial fibrillation (AF) by using "AF Stroke Risk - Atrial Fibrillation Evaluation" app. Disclaimer: all calculations must be re-checked and should not be used alone to guide patient care, nor should they substitute for clinical judgment. Calculations in this "AF Stroke Risk - Atrial Fibrillation Evaluation" app might be different with your local practice. Consult to expert doctor whenever necessary.
Screenshots
Verdict
The clearest difference is rating: MAQI2 Anticoagulation Toolkit at 4.8 against AF Stroke Risk's 1.0. MAQI2 Anticoagulation Toolkit also leads on ratings volume (8 vs 1). AF Stroke Risk's advantage is iOS requirement (12.0 vs 15). On price, update cadence, ads and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
MAQI2 Anticoagulation Toolkit holds the better App Store score, 4.8 against 1.0. That said, the two scores are not equally well evidenced: MAQI2 Anticoagulation Toolkit has 8 ratings behind it against 1, so its average is the more settled of the two.
MAQI2 Anticoagulation Toolkit ships an update every 4 months, AF Stroke Risk every 3 months. The most recent releases landed on November 4, 2026 and November 3, 2026 respectively.
| Parameter | MAQI2 Anticoagulation Toolkit | AF Stroke Risk |
|---|---|---|
| Price | Free | Free |
| Rating | 4.8 (8 ratings) — better | 1.0 (1 ratings) |
| Positive reviews | 100.0% of reviews | — |
| Number of ratings | 8 — better | 1 |
| Update frequency | Every 4 months | Every 3 months — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPod | iPhone, iPad, iPod — better |
| Requires iOS | 15 | 12.0 — better |
| Further details — not scored | ||
| Size | 6 MB | 37 MB |
| Age rating | 17+ | 12+ |
| Developer | The University of Michigan | Putu Angga Risky Raharja |
Customer experience
MAQI2 Anticoagulation Toolkit
AF Stroke Risk
In-app purchases
MAQI2 Anticoagulation Toolkit
No in-app purchases
AF Stroke Risk
No in-app purchases
